Transcatheter treatment of chronic mitral regurgitation with the MitraClip system: An Italian consensus statement

Journal of Cardiovascular Medicine

Volumn 15, Issue 3, 2014, Pages 173-188

  Maisano, Francesco ^a   Alamanni, Francesco ^b   Alfieri, Ottavio ^a   Bartorelli, Antonio ^b   Bedogni, Francesco ^c   Bovenzi, Francesco M ^d   Bruschi, Giuseppe ^e   Colombo, Antonio ^a   Cremonesi, Alberto ^f   Denti, Paolo ^a   Ettori, Federica ^g   Klugmann, Silvio ^e   La Canna, Giovanni ^a   Martinelli, Luigi ^e   Menicanti, Lorenzo ^h   Metra, Marco ^g   Oliva, Fabrizio ^e   Padeletti, Luigi ⁱ   Parolari, Alessandro ^b   Santini, Francesco ^j   Senni, Michele ^k   Tamburino, Corrado ^l   Ussia, Gian P ^m   Romeo, Francesco ^m   more..

^a SAN RAFFAELE HOSPITAL   (Italy)

^b CENTRO CARDIOLOGICO MONZINO   (Italy)

^c Istituto Clinico S Ambrogio   (Italy)

^d CAMPO DI MARTE HOSPITAL   (Italy)

^e OSPEDALE NIGUARDA CA GRANDA   (Italy)

^f MARIA CECILIA HOSPITAL   (Italy)

^g SPEDALI CIVILI   (Italy)

^h IRCCS POLICLINICO SAN DONATO   (Italy)

ⁱ CAREGGI UNIVERSITY HOSPITAL   (Italy)

^j Ospedale Civile di Genova Sampierdarena   (Italy)

^k PAPA GIOVANNI XXIII HOSPITAL   (Italy)

^l Ospedale Ferrarotto   (Italy)

^m Tor Vergata Polyclinc   (Italy)

more..

Author keywords

MitraClip; percutaneous mitral repair; transcatheter

Indexed keywords

ALDOSTERONE ANTAGONIST; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDRALAZINE; ISOSORBIDE DINITRATE; NITROPRUSSIDE SODIUM; VASODILATOR AGENT;

ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; CARDIOVASCULAR MORTALITY; DEGENERATIVE DISEASE; ECHOCARDIOGRAPHY; HEART ATRIUM ENLARGEMENT; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART HYPERTROPHY; HEART LEFT ATRIUM PRESSURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE OVERLOAD; HEART MUSCLE CONTRACTILITY; HEART MUSCLE REVASCULARIZATION; HEART STROKE VOLUME; HEART TRANSPLANTATION; HEART VALVE REPLACEMENT; HEART VENTRICLE REMODELING; HEMODYNAMICS; HUMAN; IMPLANTABLE CLIP; MEDICAL HISTORY; MITRAL ANNULOPLASTY; MITRAL VALVE PROLAPSE; MITRAL VALVE REGURGITATION; PATIENT SELECTION; PHASE 2 CLINICAL TRIAL (TOPIC); PULMONARY HYPERTENSION; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); TRANSCATHETER MITRAL VALVE IMPLANTATION; CHRONIC DISEASE; CONSENSUS DEVELOPMENT; DEVICES; EQUIPMENT DESIGN; HEART CATHETERIZATION; MINIMALLY INVASIVE SURGERY; MITRAL VALVE; MITRAL VALVE INSUFFICIENCY; PATIENT CARE; PROCEDURES; PROSTHESES AND ORTHOSES; PROSTHESIS IMPLANTATION; SURGERY;

CARDIAC CATHETERIZATION; CHRONIC DISEASE; EQUIPMENT DESIGN; HUMANS; MINIMALLY INVASIVE SURGICAL PROCEDURES; MITRAL VALVE; MITRAL VALVE INSUFFICIENCY; PATIENT CARE TEAM; PATIENT SELECTION; PROSTHESES AND IMPLANTS; PROSTHESIS IMPLANTATION;

EID: 84897422558     PISSN: 15582027     EISSN: 15582035     Source Type: Journal    
DOI: 10.2459/JCM.0000000000000004     Document Type: Article

References (116)

1. Maisano F, Franzen O, Baldus S, et al. Percutaneous mitral valve interventions in the real world: early and one year results from the ACCESS-EU, a prospective, multicenter, non-randomized post-approval study of the MitraClip(R) therapy in Europe. J Am Coll Cardiol 2013; 62:1052-1061.
2. Maisano F, Taramasso M, Cioni M, et al. Review of the MitraClip clinical evidence. Miner Cardioangiol 2012; 60:85-93.
3. Feldman T, Foster E, Glower DD, et al. Percutaneous repair or surgery for mitral regurgitation. N Engl J Med 2011; 364:1395-1406.
4. Sarris GE, Cahill PD, Hansen DE, Derby GC,Miller DC. Restoration of left ventricular systolic performance after reattachment of the mitral chordae tendineae. The importance of valvular-ventricular interaction. J Thorac Cardiovasc Surg 1988; 95:969-979.
5. Westaby S. Preservation of left ventricular function in mitral valve surgery. Heart 1996; 75:326-329.
6. Yun KL, Sintek CF, Miller DC, et al. Randomized trial comparing partial versus complete chordal-sparing mitral valve replacement: effects on left ventricular volume and function. J Thorac Cardiovasc Surg 2002; 123:707-714.
7. Zile MR, Tomita M, Ishihara K, et al. Changes in diastolic function during development and correction of chronic LV volume overload produced by mitral regurgitation. Circulation 1993; 87:1378-1388.
8. Beeri R, Yosefy C, Guerrero JL, et al. Early repair of moderate ischemic mitral regurgitation reverses left ventricular remodeling: a functional and molecular study. Circulation 2007; 116:I288-I293.
9. Everett TH, Verheule S, Wilson EE, Foreman S, Olgin JE. Left atrial dilatation resulting from chronic mitral regurgitation decreases spatiotemporal organization of atrial fibrillation in left atrium. Am J Physiol Heart Circ Physiol 2004; 286:H2452-H2460.
10. Grigioni F, Avierinos JF, Ling LH, et al. Atrial fibrillation complicating the course of degenerative mitral regurgitation: determinants and long-term outcome. J Am Coll Cardiol 2002; 40:84-92.
11. Fornes P, Heudes D, Fuzellier JF, Tixier D, Bruneval P, Carpentier A. Correlation between clinical and histologic patterns of degenerative mitral valve insufficiency: a histomorphometric study of 130 excised segments. Cardiovasc Pathol 1999; 8:81-92.
12. Agricola E, Oppizzi M, Maisano F, et al. Echocardiographic classification of chronic ischemic mitral regurgitation caused by restricted motion according to tethering pattern. Eur J Echocardiogr 2004; 5:326-334.
13. Kwan J, Shiota T, Agler DA, et al. Geometric differences of the mitral apparatus between ischemic and dilated cardiomyopathy with significant mitral regurgitation. Circulation 2003; 107:1135-1140.
14. Singh JP, Evans JC, Levy D, et al. Prevalence and clinical determinants of mitral, tricuspid, and aortic regurgitation (The Framingham Heart Study). Am J Cardiol 1999; 83:897-902; Erratum 1999; 84:1143.
15. Nkomo VT, Gardin JM, Skelton TN, Gottdiener JS, Scott CG, Enriquez- Sarano M. Burden of valvular heart diseases: a population-based study. Lancet 2006; 368:1005-1011.
16. Enriquez-Sarano M, Akins CW, Vahanian A. Mitral regurgitation. Lancet 2009; 373:1382-1394.
17. Allen LA, Felker GM. Advances in the surgical treatment of heart failure. Curr Opin Cardiol 2008; 23:249-253.
18. Nieminen MS, Brutsaert D, Dickstein K, et al. EuroHeart Failure Survey II (EHFS II): a survey on hospitalized acute heart failure patients - description of population. Eur Heart J 2006; 27:2725-2736.
19. Varadarajan P, Sharma S, Heywood JT, Pai RG. High prevalence of clinically silent severe mitral regurgitation in patients with heart failure: role for echocardiography. J Am Soc Echocardiogr 2006; 19:1458-1461.
20. Maggioni AP, Gorini M, Lucci D, et al., on behalf of IN-HF Outcome Investigators. Prevalence and outcomes of patients with chronic HF with moderate-severe mitral regurgitation: data from the IN-HF Outcome database. Eur J Heart Fail 2012; 1 (Suppl 1):1141.
21. Cioffi G, Tarantini L, De Feo S, et al. Functional mitral regurgitation predicts 1-year mortality in elderly patients with systolic chronic heart failure. Eur J Heart Fail 2005; 7:1112-1117.
22. Robbins JD, Maniar PB, Cotts W, Parker MA, Bonow RO, Gheorghiade M. Prevalence and severity of mitral regurgitation in chronic systolic heart failure. Am J Cardiol 2003; 91:360-362.
23. Palardy M, Stevenson LW, Tasissa G, et al. Reduction in mitral regurgitation during therapy guided by measured filling pressures in the ESCAPE trial. Circ Heart Fail 2009; 2:181-188.
24. Rosen SE, Borer JS, Hochreiter C, et al. Natural history of the asymptomatic/minimally symptomatic patient with severe mitral regurgitation secondary to mitral valve prolapse and normal right and left ventricular performance. Am J Cardiol 1994; 74:374-380.
25. Rosenhek R, Rader F, Klaar U, et al. Outcome of watchful waiting in asymptomatic severe mitral regurgitation. Circulation 2006; 113:2238- 2244.
26. Enriquez-Sarano M, Avierinos JF, Messika-Zeitoun D, et al. Quantitative determinants of the outcome of asymptomatic mitral regurgitation. N Engl J Med 2005; 352:875-883.
27. Avierinos JF, Gersh BJ, Melton LJ 3rd, et al. Natural history of asymptomatic mitral valve prolapse in the community. Circulation 2002; 106:1355-1361.
28. Ling LH, EnriquezSarano M, Seward JB, et al. Clinical outcome of mitral regurgitation due to flail leaflet. N Engl J Med 1996; 335:1417- 1423.
29. Trichon BH, Felker GM, Shaw LK, Cabell CH, O'Connor CM. Relation of frequency and severity of mitral regurgitation to survival among patients with left ventricular systolic dysfunction and heart failure. Am J Cardiol 2003; 91:538-543.
30. Mehra MR, Reyes P, Benitez RM, Zimrin D, Gammie JS. Surgery for severe mitral regurgitation and left ventricular failure: what do we really know? J Card Fail 2008; 14:145-150.
31. Patel JB, Borgeson DD, Barnes ME, Rihal CS, Daly RC, Redfield MM. Mitral regurgitation in patients with advanced systolic heart failure. J Cardiac Fail 2004; 10:285-291.
32. Bursi F, Barbieri A, Grigioni F, et al. Prognostic implications of functional mitral regurgitation according to the severity of the underlying chronic heart failure: a long-term outcome study. Eur J Heart Fail 2010; 12:382- 388.
33. Stevenson LW, Bellil D, Grover-McKay M, et al. Effects of afterload reduction (diuretics and vasodilators) on left ventricular volume and mitral regurgitation in severe congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 1987; 60:654-658.
34. Hamilton MA, Stevenson LW, Child JS, Moriguchi JD, Walden J, Woo M. Sustained reduction in valvular regurgitation and atrial volumes with tailored vasodilator therapy in advanced congestive heart failure secondary to dilated (ischemic or idiopathic) cardiomyopathy. Am J Cardiol 1991; 67:259-263.
35. Kizilbash AM, Willett DL, Brickner ME, Heinle SK,Grayburn PA. Effects of afterload reduction on vena contracta width in mitral regurgitation. J Am Coll Cardiol 1998; 32:427-431.
36. McMurray JJ, Adamopoulos S, Anker SD, et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail 2012; 14:803-869.
37. Hall SA, Cigarroa CG, Marcoux L, Risser RC, Grayburn PA, Eichhorn EJ. Time course of improvement in left ventricular function, mass and geometry in patients with congestive heart failure treated with betaadrenergic blockade. J Am Coll Cardiol 1995; 25:1154-1161.
38. Capomolla S, Febo O, Gnemmi M, et al. Beta-blockade therapy in chronic heart failure: diastolic function and mitral regurgitation improvement by carvedilol. Am Heart J 2000; 139:596-608.
39. Nemoto S, Hamawaki M, De Freitas G, Carabello BA. Differential effects of the angiotensin-converting enzyme inhibitor lisinopril versus the betaadrenergic receptor blocker atenolol on hemodynamics and left ventricular contractile function in experimental mitral regurgitation. J Am Coll Cardiol 2002; 40:149-154.
40. Carabello BA. The current therapy for mitral regurgitation. J Am Coll Cardiol 2008; 52:319-326.
41. Heinle SK, Tice FD, Kisslo J. Effect of dobutamine stress echocardiography on mitral regurgitation. J Am Coll Cardiol 1995; 25:122-127.
42. Kanzaki H, Bazaz R, Schwartzman D, Dohi K, Sade LE, Gorcsan J. A mechanism for immediate reduction in mitral regurgitation after cardiac resynchronization therapy: insights from mechanical activation strain mapping. J Am Coll Cardiol 2004; 44:1619-1625.
43. Pierard LA, Carabello BA. Ischaemic mitral regurgitation: pathophysiology, outcomes and the conundrum of treatment. Eur Heart J 2010; 31:2996-3005.
44. Ypenburg C, Lancellotti P, Tops LF, et al. Mechanism of improvement in mitral regurgitation after cardiac resynchronization therapy. Eur Heart J 2008; 29:757-765.
45. Breithardt OA, Sinha AM, Schwammenthal E, et al. Acute effects of cardiac resynchronization therapy on functional mitral regurgitation in advanced systolic heart failure. J Am Coll Cardiol 2003; 41:765-770. Erratum 2003; 41:1852.
46. Verhaert D, Popovic ZB, De S, et al. Impact of mitral regurgitation on reverse remodeling and outcome in patients undergoing cardiac resynchronization therapy. Circ Cardiovasc Imaging 2012; 5:U21-U49.
47. Sitges M, Vidal B, Delgado V, et al. Long-term effect of cardiac resynchronization therapy on functional mitral valve regurgitation. Am J Cardiol 2009; 104:383-388.
48. Marsan NA, Westenberg JJ, Ypenburg C, et al. Magnetic resonance imaging and response to cardiac resynchronization therapy: relative merits of left ventricular dyssynchrony and scar tissue. Eur Heart J 2009; 30:2360-2367.
49. Ypenburg C, Lancellotti P, Tops LF, et al. Acute effects of initiation and withdrawal of cardiac resynchronization therapy on papillary muscle dyssynchrony and mitral regurgitation. J Am Coll Cardiol 2007; 50:2071-2077.
50. Ypenburg C, van Bommel RJ, Borleffs CJ, et al. Long-term prognosis after cardiac resynchronization therapy is related to the extent of left ventricular reverse remodeling at midterm follow-up. J Am Coll Cardiol 2009; 53:483-490.
51. Bonow RO, Carabello BA, Chatterjee K, et al. 2008 focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1998 guidelines for the management of patients with valvular heart disease). Endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol 2008; 52:e1-e142.
52. Vahanian A, Alfieri O, Andreotti F, et al. Guidelines on the management of valvular heart disease (version 2012): the Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 2012; 33:2451-2496.
53. Tribouilloy CM, Enriquez-Sarano M, Schaff HV, et al. Impact of preoperative symptoms on survival after surgical correction of organic mitral regurgitation: rationale for optimizing surgical indications. Circulation 1999; 99:400-405.
54. Crawford MH, Souchek J, Oprian CA, et al. Determinants of survival and left ventricular performance after mitral valve replacement. Department of Veterans Affairs Cooperative Study on Valvular Heart Disease. Circulation 1990; 81:1173-1181.
55. Dujardin KS, Seward JB, Orszulak TA, et al. Outcome after surgery for mitral regurgitation. Determinants of postoperative morbidity and mortality. J Heart Valve Dis 1997; 6:17-21.
56. Enriquez-Sarano M, Tajik AJ, Schaff HV, et al. Echocardiographic prediction of left ventricular function after correction of mitral regurgitation: results and clinical implications. J Am Coll Cardiol 1994; 24:1536-1543.
57. Enriquezsarano M, Tajik AJ, Schaff HV, Orszulak TA, Bailey KR, Frye RL. Echocardiographic prediction of survival after surgical-correction of organic mitral regurgitation. Circulation 1994; 90:830-837.
58. Nashef SA, Roques F, Michel P, Gauducheau E, Lemeshow S, Salamon R. European System for Cardiac Operative Risk Evaluation (EuroSCORE). Eur J Cardiothorac Surg 1999; 16:9-13.
59. Enriquez-Sarano M, Rossi A, Seward JB, Bailey KR, Tajik AJ. Determinants of pulmonary hypertension in left ventricular dysfunction. J Am Coll Cardiol 1997; 29:153-159.
60. Gammie JS, O'Brien SM, Griffith BP, Ferguson TB, Peterson ED. Influence of hospital procedural volume on care process and mortality for patients undergoing elective surgery for mitral regurgitation: response. Circulation 2007; 116:E147-E1147.
61. STS 2012 Executive Summary. Adult Cardiac Surgery Results http:// www.sts.org/sts-national-database/database-managers/executivesummaries.
62. Bolling SF, Li S, O'Brien SM, Brennan JM, Prager RL, Gammie JS. Predictors of mitral valve repair: clinical and surgeon factors. Ann Thorac Surg 2010; 90:1904-1911; discussion 1912.
63. Carpentier A. Cardiac valve surgery: the 'French correction'. J Thorac Cardiovasc Surg 1983; 86:323-337.
64. David TE, Bos J, Rakowski H. Mitral valve repair by replacement of chordae tendineae with polytetrafluoroethylene sutures. J Thorac Cardiovasc Surg 1991; 101:495-501.
65. Sousa Uva M, Grare P, Jebara V, et al. Transposition of chordae in mitral valve repair: mid-term results. Circulation 1993; 88:II35-II38.
66. Alfieri O, Maisano F, De Bonis M, et al. The double-orifice technique in mitral valve repair: a simple solution for complex problems. J Thorac Cardiovasc Surg 2001; 122:674-681.
67. Carpentier A, Adams DH, Filsoufi F. Carpentier's reconstructive valve surgery. W.B Saunders; 2010.
68. Barlow CW, Ali ZA, Lim E, Barlow JB, Wells FC. Modified technique for mitral repair without ring annuloplasty. Ann Thorac Surg 2003; 75:298- 300.
69. Duebener LF, Wendler O, Nikoloudakis N, Georg T, Fries R, Schafers HJ. Mitral-valve repair without annuloplasty rings: results after repair of anterior leaflet versus posterior-leaflet defects using polytetrafluoroethylene sutures for chordal replacement. Eur J Cardiothorac Surg 2000; 17:206-212.
70. Savage EB, Ferguson TB, DiSesa VJ. Use of mitral valve repair: analysis of contemporary United States experience reported to the Society of Thoracic Surgeons National Cardiac Database. Ann Thorac Surg 2003; 75:820-825.
71. Heikkinen J, Biancari F, Satta J, Salmela E, Juvonen T, Lepojarvi M. Quality of life after mitral valve repair. J Heart Valve Dis 2005; 14:722-726.
72. Maisano F, Vigano G, Calabrese C, et al. Quality of life of elderly patients following valve surgery for chronic organic mitral regurgitation. Eur J Cardiothorac Surg 2009; 36:261-266.
73. Filsoufi F, Salzberg SP, Adams DH. Current management of ischemic mitral regurgitation. Mt Sinai J Med 2005; 72:105-115.
74. Gillinov AM, Wierup PN, Blackstone EH, et al. Is repair preferable to replacement for ischemic mitral regurgitation? J Thorac Cardiovasc Surg 2001; 122:1125-1141.
75. Grossi EA, Goldberg JD, LaPietra A, et al. Ischemic mitral valve reconstruction and replacement: comparison of long-term survival and complications. J Thorac Cardiovasc Surg 2001; 122:1107-1124.
76. Miller DC. Ischemic mitral regurgitation redux: to repair or to replace? J Thorac Cardiovasc Surg 2001; 122:1059-1062.
77. Aklog L, Filsoufi F, Flores KQ, et al. Does coronary artery bypass grafting alone correct moderate ischemic mitral regurgitation? Circulation 2001; 104:I68-I75.
78. Calafiore AM, Di Mauro M, Gallina S, et al. Mitral valve surgery for chronic ischemic mitral regurgitation. Ann Thorac Surg 2004; 77:1989- 1997.
79. Gangemi JJ, Tribble CG, Ross SD, McPherson JA, Kern JA, Kron IL. Does the additive risk of mitral valve repair in patients with ischemic cardiomyopathy prohibit surgical intervention? Ann Surg 2000; 231:710-714.
80. Adams DH, Filsoufi F, Aklog L. Surgical treatment of the ischemic mitral valve. J Heart Valve Dis 2002; 11 (Suppl 1):S21-S25.
81. Braun J, van de Veire NR, Klautz RJ, et al. Restrictive mitral annuloplasty cures ischemic mitral regurgitation and heart failure. Ann Thorac Surg 2008; 85:430-436; discussion 436-437.
82. David TE, Uden DE, Strauss HD. The importance of the mitral apparatus in left ventricular function after correction of mitral regurgitation. Circulation 1983; 68:II76-II82.
83. David TE, Armstrong S, Sun Z. Left ventricular function after mitral valve surgery. J Heart Valve Dis 1995; 4 (Suppl 2):S175-S180.
84. Bach DS, Bolling SF. Early improvement in congestive heart failure after correction of secondary mitral regurgitation in end-stage cardiomyopathy. Am Heart J 1995; 129:1165-1170.
85. Bolling SF, Deeb GM, Brunsting LA, Bach DS. Early outcome of mitral valve reconstruction in patients with end-stage cardiomyopathy. J Thorac Cardiovasc Surg 1995; 109:676-682; discussion 682-683.
86. McGee EC, Gillinov AM, Blackstone EH, et al. Recurrent mitral regurgitation after annuloplasty for functional ischemic mitral regurgitation. J Thorac Cardiovasc Surg 2004; 128:916-924.
87. Magne J, Senechal M, Mathieu P, Dumesnil JG, Dagenais F, Pibarot P. Restrictive annuloplasty for ischemic mitral regurgitation may induce functional mitral stenosis. J Am Coll Cardiol 2008; 51:1692-1701.
88. Borger MA, Alam A, Murphy PM, Doenst T, David TE. Chronic ischemic mitral regurgitation: repair, replace or rethink? Ann Thorac Surg 2006; 81:1153-1161.
89. Hung J, Papakostas L, Tahta SA, et al. Mechanism of recurrent ischemic mitral regurgitation after annuloplasty: continued LV remodeling as a moving target. Circulation 2004; 110:Ii85-Ii90.
90. Grossi EA, Bizekis CS, LaPietra A, et al. Late results of isolated mitral annuloplasty for 'functional' ischemic mitral insufficiency. J Cardiac Surg 2001; 16:328-332
91. Alfieri O, Lorusso R. The double-orifice technique for mitral valve reconstruction: predictors of postoperative outcome - conference discussion. Eur J Cardiothorac Surg 2001; 20:583-589.
92. Maisano F, Caldarola A, Blasio A, De Bonis M, La Canna G, Alfieri O. Midterm results of edge-to-edge mitral valve repair without annuloplasty. J Thorac Cardiovasc Surg 2003; 126:1987-1997.
93. Bhudia SK, McCarthy PM, Smedira NG, Lam BK, Rajeswaran J, Blackstone EH. Edge-to-edge (Alfieri) mitral repair: results in diverse clinical settings. Ann Thorac Surg 2004; 77:1598-1606.
94. Sartipy U, Albage A, Mattsson E, Lindblom D. Edge-to-edge mitral repair without annuloplasty in combination with surgical ventricular restoration. Ann Thorac Surg 2007; 83:1303-1309.
95. Bhattacharya S, He Z. Annulus tension of the prolapsed mitral valve corrected by edge-to-edge repair. J Biomech 2012; 45:562-568.
96. Maisano F, Vigano G, Blasio A, Colombo A, Calabrese C, Alfieri O. Surgical isolated edge-to-edge mitral valve repair without annuloplasty: clinical proof of the principle for an endovascular approach. EuroIntervention 2006; 2:181-186.
97. Bax JJ, Braun J, Somer ST, et al. Restrictive annuloplasty and coronary revascularization in ischemic mitral regurgitation results in reverse left ventricular remodeling. Circulation 2004; 110:Ii103-Ii108.
98. Maisano F, Schreuder JJ, Oppizzi R, Fiorani B, Fino C, Alfieri O. The double-orifice technique as a standardized approach to treat mitral regurgitation due to severe myxomatous disease: surgical technique. Eur J Cardiothorac Surg 2000; 17:201-205.
99. Maisano F, Torracca L, Oppizzi M, et al. The edge-to-edge technique: a simplified method to correct mitral insufficiency. Eur J Cardiothorac Surg 1998; 13:240-245.
100. Condado JA, Acquatella H, Rodriguez L, Whitlow P, Velez-Gimo M, St Goar FG. Percutaneous edge-to-edge mitral valve repair: 2-year followup in the first human case. Catheter Cardiovasc Interv 2006; 67:323- 325.
101. Argenziano M, Skipper E, Heimansohn D, et al. Surgical revision after percutaneous mitral repair with the MitraClip device. Ann Thorac Surg 2010; 89:72-80.
102. Feldman T, Kar S, Rinaldi M, et al. Percutaneous mitral repair with the MitraClip system safety and midterm durability in the initial EVEREST (Endovascular Valve Edge-to-Edge REpair Study) cohort. J Am Coll Cardiol 2009; 54:686-694.
103. Feldman T, Wasserman HS, Herrmann HC, et al. Percutaneous mitral valve repair using the edge-to-edge technique: six-month results of the EVEREST phase I clinical trial. J Am Coll Cardiol 2005; 46:2134- 2140.
104. George JC, Varghese V, Dangas G, Feldman TE. Percutaneous mitral valve repair: lessons from the EVEREST II (Endovascular Valve Edge-to-Edge REpair Study) and beyond. JACC Cardiovasc Interv 2011; 4:825-827.
105. Glower D, Ailawadi G, Argenziano M, et al. EVEREST II randomized clinical trial: predictors of mitral valve replacement in de novo surgery or after the MitraClip procedure. J Thorac Cardiovasc Surg 2012; 143:S60-S63.
106. Goldberg SL, Feldman T. Percutaneous mitral valve interventions: overview of new approaches. Curr Cardiol Rep 2010; 12:404-412.
107. Herrmann HC, Gertz ZM, Silvestry FE, et al. Effects of atrial fibrillation on treatment of mitral regurgitation in the EVEREST II (Endovascular Valve Edge-to-Edge Repair Study) randomized trial. J Am Coll Cardiol 2012; 59:1312-1319.
108. Herrmann HC, Kar S, Siegel R, et al. Effect of percutaneous mitral repair with the MitraClip (R) device on mitral valve area and gradient. EuroIntervention 2009; 4:437-442.
109. Herrmann HC, Rohatgi S, Wasserman HS, et al. Mitral valve hemodynamic effects of percutaneous edge-to-edge repair with the MitraClip device for mitral regurgitation. Catheter Cardiovasc Interv 2006; 68:821-828.
110. Ladich E, Michaels MB, Jones RM, et al. Pathological healing response of explanted MitraClip devices. Circulation 2011; 123:1418-1427.
111. Mauri L, Garg P, Massaro JM, et al. The EVEREST II trial: design and rationale for a randomized study of the evalve MitraClip system compared with mitral valve surgery for mitral regurgitation. Am Heart J 2010; 160:23-29.
112. Siegel RJ, Biner S, Rafique AM, et al. The acute hemodynamic effects of MitraClip therapy. J Am Coll Cardiol 2011; 57:1658-1665.
113. Silvestry FE, Rodriguez LL, Herrmann HC, et al. Echocardiographic guidance and assessment of percutaneous repair for mitral regurgitation with the evalve MitraClip: lessons learned from EVEREST I. J Am Soc Echocardiogr 2007; 20:1131-1140.
114. Whitlow PL, Feldman T, Pedersen WR, et al. Acute and 12-month results with catheter-based mitral valve leaflet repair: the EVEREST II (Endovascular Valve Edge-to-Edge Repair) High Risk Study. J Am Coll Cardiol 2012; 59:130-139.
115. Turi ZG, Rosenbloom M. An option for the high-comorbidity patient with mitral regurgitation. J Am Coll Cardiol 2012; 59:140-142.
116. McMurray JJ, Adamopoulos S, Anker SD, et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J 2012; 33:1787-1847.